Mouse antibody for CA19-9 capture in FIA/CLIA applications. Detects tumor marker associated with pancreatic cancer, gallbladder cancer, colon cancer, and gastric cancer.
Manufactured by
Shenzhen, Guangdong, China
HeavyBio Inc. is a young expert in IVD raw materials for cardiac markers, tumor markers, inflammatory markers, neuroendocrine and infectious diseases, which has been committed to becoming the world's leading IVD reagent supplier since 2017. Based in Shenzhen, China, the company develops, manufactures and commercializes high-quality monoclonal antibodies, recombinant antibodies, antigens, etc., which are widely used in ELISA, CLIA, latex and rapid test platforms. Innovation and quality are our top priorities, market and customer orientation are our constant endeavors. HeavyBio Inc. has been at the forefront of fighting the Covid-19 pandemic since 2020, thanks to a professional team of more than 60% R D and technical service experts, which has earned a good reputation in the IVD field in China. HeavyBio Inc. is your trusted Chinese IVD solution provider and raw material specialist!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
BiosPacific
United States · 3 relevant products
Boditech Med Inc.
South Korea · 3 relevant products
Anbio Biotechnology Limited
Germany · 3 relevant products
Medix Biochemica Oy AB
Finland · 2 relevant products
VEDALAB SAS
France · 5 relevant products
Nanjing Poclight Biotechnology Co.,Ltd.
China · 3 relevant products
Institute of Isotopes Co. Ltd.
Hungary · 1 relevant product
Fujirebio Diagnostics,Inc.
China · 4 relevant products
Healgen Scientific LLC
United States · 1 relevant product
31 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 80 closest product alternatives
J. Mitra & Co. Pvt. Ltd. · India
Tumor marker assay kit for CA19-9 detection using chemiluminescence immunoassay. Analytical sensitivity of 1.50 U/mL with linearity from 1.50 to 1000 U/mL.
BiosPacific · United States
High-quality antibodies for CA19-9 cancer marker detection and immunoassay development. Essential for pancreatic and gastrointestinal cancer diagnostics.
Boditech Med Inc. · South Korea
A diagnostic test reagent that supports the diagnosis of pancreatic cancer.
Anbio Biotechnology Limited · Germany
Immunoassay for carbohydrate antigen 19-9 measurement in clinical specimens. Supports pancreatic and biliary cancer monitoring.
Medix Biochemica Oy AB · Finland
A diagnostic test for measuring Cancer Antigen 19-9 (CA19-9) levels in blood samples. This test is used in clinical laboratories for cancer screening and monitoring, particularly for gastrointestinal cancers.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 19-9 (CA 19-9) in whole blood, serum or plasma. Measuring range: 30-1000 U/mL. Reading time: 15 minutes.
Nanjing Poclight Biotechnology Co.,Ltd. · China
An in vitro quantitative test kit using homogeneous chemiluminescence immunoassay for determination of Carbohydrate Antigen 19-9 in human serum and plasma. The test is used as an aid in the diagnosis of pancreatic cancer. For professional and laboratory use only, with 18 months shelf life and storage at 2-30°C without cold chain requirement.
Institute of Isotopes Co. Ltd. · Hungary
CA19-9 is a tumour associated mucin-type high molecular weight glycoprotein antigen circulating in the blood and can be found in tissues. This test is useful in monitoring patients with confirmed pancreatic cancer whose CA19-9 levels are above the cut off at the time of the diagnosis. Patients negative for the Lewis blood group antigen have no CA 19-9 in their blood even in the presence of malignant disease.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 19-9 (CA 19-9) in whole blood, serum or plasma. Measuring range: 30–1000 U/mL. Reading time: 15 minutes.
Fujirebio Diagnostics,Inc. · China
An in vitro diagnostic test kit for the detection of cancer antigen 19-9 (CA19-9), a tumor marker. The product is CE certified and complies with European in vitro diagnostic product directive 98/79/EC. It is manufactured by ISO13485 certified facilities in Gothenburg, Sweden and Malvern, Pennsylvania, USA.
Healgen Scientific LLC · United States
CLIA-waived rapid immunofluorescence assay (FIA) test kit for qualitative detection of fentanyl in oral fluid samples. Enables quick screening in clinical and point-of-care settings with 510(k) clearance for reliable drug presence identification.
BiosPacific · United States
Affinity purified antibodies for CA-125 biomarker detection in cancer diagnostics. Supports immunoassay platforms for ovarian and other cancer monitoring.
68 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products